pain

Unemployment Risk Factors in MS Vary with Age, Study Suggests

Physical symptoms and poorer coping mechanisms are major risk factors for unemployment in younger and older people with multiple sclerosis (MS), while psychological problems have the greatest impact in middle-aged patientsā€™ unemployment, a study suggests. These findings highlight that unemployment risk factors vary with age and call for interventions…

We All Have Bad Days

Mama said there would be days like this. I just never thought there would be so many. After three days of insomnia, I am heavily fatigued and weary. I wait, bleary-eyed, for signs of pain to appear, watching the sunrise and praying for renewal. As if on cue, the birds…

Axim Improves Delivery of Cannabinoids in Chewing Gums

Axim Biotechnologies announced that it has succeeded in microencapsulating cannabinoids (chemical compounds in cannabis) into the companyā€™s patented chewing gums, which are used to treat several disease symptoms, including pain and spasticity associated withĀ multiple sclerosis (MS). Since the active cannabinoids are degradable in the body, the company needed…

Stanford Researchers Open Medical Cannabis Company with Oral Therapy for MS Pain, Spasticity as Initial Goal

A new medical cannabis company calledĀ Katexco PharmaceuticalsĀ aims to develop oral therapies that harness the brain’s endocannabinoid and nicotine receptors to treat inflammatory diseases such as multiple sclerosis. Co-founded by two Stanford University researchers ā€” Jonathan Rothbard, PhD, and Lawrence Steinman, MD ā€” Katexco will leverage their expertise…

MedChew RX Shows Stability and Potential for Effectiveness in Early Tests, Company Reports

AXIM BiotechĀ announced that tests done on itsĀ cannabinoid-based chewing gum ā€”Ā MedChew RxĀ ā€” showed both product stability and effective release of medicinal molecules,Ā with a high percentage of itsĀ pharmaceutical ingredients available. These test results may be of importance, as the company is planning to bring MedChew Rx into clinical trials as a…

Sativex Relieves Pain in MS Patients, Italian Study Confirms

Researchers confirmed that Sativex spray is beneficial in alleviating pain in patients with multiple sclerosis (MS), and also improved their pain sensitivity to cold temperatures. The study reporting the findings, ā€œPain Modulation after Oromucosal Cannabinoid Spray (SATIVEX) in Patients with Multiple Sclerosis: A Study with Quantitative…

My Scars Are Beautiful

Our life experiences shape and define who we are. While some wash over us and dissipate, others leave indelible impressions. Both emotional and physical, our scars hold our past and influence our future. We are the totality of these scars and their narrative is powerful. Each is a chapter in…

My Solemn Truth on Pain and Suffering

As some have said, ā€œPain is inevitable; suffering is optional.ā€ I believe I am an optimistic, grateful, and spiritual woman. With that said, I must acknowledge that I have an irresolute reaction when I hear that suffering is optional. Suffering is defined as the state of undergoing pain, distress,…

GeneFo Guide Explains How Medical Cannabis Can Help MS Patients

More studies are showing that medical cannabis can alleviate symptoms of multiple sclerosis (MS), according to a company that helps patients, doctors and others understand genetic conditions better. The observation came inĀ GeneFo’sĀ 2018 Guide to Clinical Effects of Medical Cannabis. Some research has suggested that cannabis strains containing…

Pain Affect in MS Associated with Physical and Psychiatric Comorbidities

Physical and psychiatric comorbidities in multiple sclerosisĀ (MS)Ā patientsĀ are associated with an increased risk of experiencing more pain ā€” namely pain intensity and pain affect. The research to support that finding, ā€œPsychiatric and physical comorbidities and pain in patients with multiple sclerosis,ā€ was published in the Journal of Pain…

Holland Approves Clinical Trial Plans for AXIM’s Cannabis-based Gum for MS Pain and Spasticity

Dutch regulators have signed off onĀ AXIM Biotechnologies’Ā clinical trial plans forĀ a chewing gum that offers controlled release of cannabinoids to treat multiple sclerosis patients’ pain and spasticity. The Dutch Medicines Evaluation Board’s sign-off on MedChew Rx means AXIM can start trials. A leader in cannabinoid research, New York-based AXIM…

Free Your Fascia!

One of the most frustrating aspects of my MS is a frequent feeling of tightness and pain. The sensations may be in my arms, legs, or even in the trunk of my body in the form of the “MS hug.” Gabapentin helps to keep the pain…

MMJ Hires Lead Investigator for Phase 2 Trials of Medicinal Cannabis to Treat Progressive MS

MMJ BioScience, an affiliate of medical cannabis research company MMJ International Holdings, has hired a principal investigator to lead clinical trials exploring potential therapeutic applications of cannabinoids inĀ progressive multiple sclerosis (MS). Dr. Bianca Weinstock-Guttman, a neurology professor at the State University of New York at Buffalo,Ā is executive director…